CBT 📈 Cabot - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1270551013
CBT: Rubber, Carbon, Silica, Alumina, Aerogel, Masterbatch, Inkjet
Cabot Corporation is a specialty chemicals and performance materials company that operates through two primary segments: Reinforcement Materials and Performance Chemicals. The company's product portfolio is diverse, with a focus on delivering high-performance materials that enhance the properties of various products. For instance, its reinforcing carbons are used in the production of tires, where they serve as a rubber reinforcing agent and performance additive, while also being utilized in industrial products such as hoses, belts, and molded goods. Additionally, the company offers engineered elastomer composites solutions, which cater to the needs of various industries.
The company's specialty carbons find applications in a wide range of products, including inks, coatings, plastics, adhesives, toners, batteries, and displays. Furthermore, Cabot Corporation provides conductive additives and fumed alumina, which are used in the production of lead acid and lithium-ion batteries for electric vehicles. Its fumed silica is another key product, used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals. The company also offers fumed alumina for use in various products, such as inkjet media, lighting, coatings, cosmetics, and polishing slurries, demonstrating the versatility of its product offerings.
Cabot Corporation's product range extends to include aerogel, a hydrophobic, silica-based particle used in thermal insulation and specialty chemical applications. The company also manufactures masterbatch and conductive compound products, which are utilized in a broad range of industries, including automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics. Moreover, its inkjet colorants are designed for inkjet printing applications, while the company also produces carbon nanotubes and fumed metal oxides, highlighting its commitment to innovation and meeting the evolving needs of its customers.
In terms of its market reach, Cabot Corporation sells its products through a network of distributors and sales representatives, with a global presence spanning the Americas, Europe, the Middle East, Africa, and the Asia Pacific. With a rich history dating back to 1882, the company is headquartered in Boston, Massachusetts, and has established itself as a leading player in the specialty chemicals and performance materials industry. As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol CBT, Cabot Corporation is committed to delivering value to its shareholders while maintaining its focus on innovation and customer satisfaction.
Additional Sources for CBT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CBT Stock Overview
Market Cap in USD | 5,963m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Commodity Chemicals |
IPO / Inception | 1980-11-05 |
CBT Stock Ratings
Growth 5y | 83.0% |
Fundamental | 71.1% |
Dividend | 56.4% |
Rel. Strength Industry | 745 |
Analysts | 3.6/5 |
Fair Price Momentum | 90.54 USD |
Fair Price DCF | 214.51 USD |
CBT Dividends
Dividend Yield 12m | 1.82% |
Yield on Cost 5y | 4.05% |
Annual Growth 5y | 2.61% |
Payout Consistency | 92.4% |
CBT Growth Ratios
Growth Correlation 3m | -66.8% |
Growth Correlation 12m | 85% |
Growth Correlation 5y | 95.1% |
CAGR 5y | 17.27% |
CAGR/Mean DD 5y | 1.58 |
Sharpe Ratio 12m | 0.34 |
Alpha | -24.01 |
Beta | 1.31 |
Volatility | 31.59% |
Current Volume | 212.1k |
Average Volume 20d | 414.6k |
As of December 27, 2024, the stock is trading at USD 92.74 with a total of 212,100 shares traded.
Over the past week, the price has changed by -0.08%, over one month by -15.81%, over three months by -16.59% and over the past year by +9.35%.
Yes, based on ValueRay Fundamental Analyses, Cabot (NYSE:CBT) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 71.09 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CBT as of December 2024 is 90.54. This means that CBT is currently overvalued and has a potential downside of -2.37%.
Cabot has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold CBT.
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, CBT Cabot will be worth about 100.5 in December 2025. The stock is currently trading at 92.74. This means that the stock has a potential upside of +8.41%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 117.6 | 26.8% |
Analysts Target Price | 85.4 | -7.9% |
ValueRay Target Price | 100.5 | 8.4% |